Evaxion Biotech A/S (EVAX) Institutional Ownership $1.66 -0.19 (-10.27%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$1.66 0.00 (-0.30%) As of 04:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evaxion Biotech A/S (NASDAQ:EVAX)CurrentInstitutional OwnershipPercentage11.04%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.32MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$167.94K Get EVAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Evaxion Biotech A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVAX Institutional Buying and Selling by Quarter Remove Ads Evaxion Biotech A/S Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025Invst LLC50,400$43K0.0%+16.7%4.308% 1/24/2025Catalina Capital Group LLC34,864$29K0.0%N/A2.980% 11/19/2024Invst LLC43,200$134K0.0%-20.0%0.736% 8/16/2024Invst LLC54,000$156K0.0%N/A0.998% 8/15/2024Armistice Capital LLC392,000$1.14M0.0%+6.8%7.245% 2/14/2024LM Advisors LLC337,336$231K0.0%N/A8.898% 1/9/2024Beacon Capital Management LLC48,633$33K0.0%+606.8%0.173% 10/11/2023AE Wealth Management LLC48,633$41K0.0%N/A0.176% 5/12/2023Moloney Securities Asset Management LLC36,000$41K0.0%N/A0.142% 2/14/2023Pura Vida Investments LLC16,842$30K0.0%N/A0.071% 11/17/2022Telemetry Investments L.L.C.29,000$76K0.1%-76.2%0.122% 11/16/2021Telemetry Investments L.L.C.30,743$296K0.4%-26.3%0.160% 11/12/2021Credit Suisse AG40,315$389K0.0%N/A0.210% 8/16/2021Maven Securities LTD235,606$1.76M0.1%+2.2%1.227% 8/16/2021Telemetry Investments L.L.C.41,729$315K0.4%-43.5%0.217% 5/18/2021Luminus Management LLC194,929$1.15M0.2%N/A1.015% 5/18/2021Alyeska Investment Group L.P.86,726$512K0.0%N/A0.452% 5/13/2021Kepos Capital LP37,098$219K0.0%N/A0.193% 5/12/2021Granite Point Capital Management L.P.224,601$1.33M0.0%N/A1.170% (Data available from 1/1/2016 forward)Remove Ads EVAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Evaxion Biotech A/S shares: Armistice Capital LLC ($1.14M), LM Advisors LLC ($231K), Invst LLC ($43K), AE Wealth Management LLC ($41K), Moloney Securities Asset Management LLC ($41K), and Beacon Capital Management LLC ($33K), and Catalina Capital Group LLC ($29K).Learn more on EVAX's institutional investors. What percentage of Evaxion Biotech A/S stock is owned by institutional investors? 11.04% of Evaxion Biotech A/S stock is owned by institutional investors. Learn more on EVAX's institutional investor holdings. Which institutional investors have been buying Evaxion Biotech A/S stock? The following institutional investors have purchased Evaxion Biotech A/S stock in the last 24 months: LM Advisors LLC ($337.34K), Invst LLC ($61.20K), AE Wealth Management LLC ($48.63K), Beacon Capital Management LLC ($41.75K), Moloney Securities Asset Management LLC ($36K), Catalina Capital Group LLC ($34.86K), and Armistice Capital LLC ($25K). How much institutional buying is happening at Evaxion Biotech A/S? Institutional investors have bought a total of 584,785 shares in the last 24 months. This purchase volume represents approximately $18.38M in transactions. Which Evaxion Biotech A/S major shareholders have been selling company stock? The following institutional investors have sold Evaxion Biotech A/S stock in the last 24 months: Invst LLC ($10.80K). How much institutional selling is happening at Evaxion Biotech A/S? Institutional investors have sold a total of 10,800 shares in the last 24 months. This volume of shares sold represents approximately $167.94K in transactions. Related Companies Dogwood Therapeutics Institutional Ownership Bright Green Institutional Ownership Addex Therapeutics Institutional Ownership Brainstorm Cell Therapeutics Institutional Ownership Onconetix Institutional Ownership Klotho Neurosciences Institutional Ownership Cyclerion Therapeutics Institutional Ownership Aytu BioPharma Institutional Ownership Universe Pharmaceuticals Institutional Ownership BioXcel Therapeutics Institutional Ownership This page (NASDAQ:EVAX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.